[English] 日本語
Yorodumi
- PDB-8f7o: BRAF kinase in complex with TAK580 (tovorafenib) -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 8f7o
TitleBRAF kinase in complex with TAK580 (tovorafenib)
ComponentsSerine/threonine-protein kinase B-raf
KeywordsTRANSFERASE/INHIBITOR / BRAF / TAK580 / tovorafenib / TRANSFERASE / TRANSFERASE-INHIBITOR complex
Function / homology
Function and homology information


trehalose metabolism in response to stress / CD4-positive, alpha-beta T cell differentiation / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / negative regulation of synaptic vesicle exocytosis / head morphogenesis / Signalling to p38 via RIT and RIN / myeloid progenitor cell differentiation / ARMS-mediated activation / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling ...trehalose metabolism in response to stress / CD4-positive, alpha-beta T cell differentiation / CD4-positive or CD8-positive, alpha-beta T cell lineage commitment / negative regulation of synaptic vesicle exocytosis / head morphogenesis / Signalling to p38 via RIT and RIN / myeloid progenitor cell differentiation / ARMS-mediated activation / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / endothelial cell apoptotic process / negative regulation of fibroblast migration / positive regulation of glucose transmembrane transport / establishment of protein localization to membrane / mitogen-activated protein kinase kinase binding / regulation of T cell differentiation / Negative feedback regulation of MAPK pathway / positive regulation of axonogenesis / Frs2-mediated activation / stress fiber assembly / positive regulation of axon regeneration / face development / synaptic vesicle exocytosis / somatic stem cell population maintenance / MAP kinase kinase activity / thyroid gland development / MAP kinase kinase kinase activity / negative regulation of endothelial cell apoptotic process / positive regulation of substrate adhesion-dependent cell spreading / positive regulation of stress fiber assembly / response to cAMP / cellular response to calcium ion / ERK1 and ERK2 cascade / substrate adhesion-dependent cell spreading / cellular response to nerve growth factor stimulus / thymus development / long-term synaptic potentiation / animal organ morphogenesis / Spry regulation of FGF signaling / RAF activation / Signaling by high-kinase activity BRAF mutants / visual learning / MAP2K and MAPK activation / epidermal growth factor receptor signaling pathway / response to peptide hormone / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / MAPK cascade / Signaling by BRAF and RAF1 fusions / cellular response to xenobiotic stimulus / presynapse / positive regulation of peptidyl-serine phosphorylation / T cell differentiation in thymus / T cell receptor signaling pathway / regulation of cell population proliferation / cell body / scaffold protein binding / negative regulation of neuron apoptotic process / Ras protein signal transduction / positive regulation of ERK1 and ERK2 cascade / non-specific serine/threonine protein kinase / protein kinase activity / neuron projection / protein phosphorylation / intracellular membrane-bounded organelle / protein serine kinase activity / protein serine/threonine kinase activity / calcium ion binding / protein-containing complex binding / positive regulation of gene expression / negative regulation of apoptotic process / mitochondrion / ATP binding / identical protein binding / nucleus / plasma membrane / cytosol
Similarity search - Function
Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) / Protein kinase C-like, phorbol ester/diacylglycerol-binding domain ...Raf-like Ras-binding domain / Raf-like Ras-binding / Ras-binding domain (RBD) profile. / Raf-like Ras-binding domain / Diacylglycerol/phorbol-ester binding / Phorbol esters/diacylglycerol binding domain (C1 domain) / Zinc finger phorbol-ester/DAG-type signature. / Zinc finger phorbol-ester/DAG-type profile. / Protein kinase C conserved region 1 (C1) domains (Cysteine-rich domains) / Protein kinase C-like, phorbol ester/diacylglycerol-binding domain / C1-like domain superfamily / Protein tyrosine and serine/threonine kinase / Serine-threonine/tyrosine-protein kinase, catalytic domain / Ubiquitin-like domain superfamily / Serine/threonine-protein kinase, active site / Serine/Threonine protein kinases active-site signature. / Serine/Threonine protein kinases, catalytic domain / Protein kinase, ATP binding site / Protein kinases ATP-binding region signature. / Protein kinase domain profile. / Protein kinase domain / Protein kinase-like domain superfamily
Similarity search - Domain/homology
Chem-QOP / Serine/threonine-protein kinase B-raf
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 3.54 Å
AuthorsTkacik, E. / Li, K. / Gonzalez Del-Pino, G. / Eck, M.J.
Funding support United States, 1items
OrganizationGrant numberCountry
National Institutes of Health/National Cancer Institute (NIH/NCI)5R35CA242461 United States
CitationJournal: J.Biol.Chem. / Year: 2023
Title: Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib.
Authors: Tkacik, E. / Li, K. / Gonzalez-Del Pino, G. / Ha, B.H. / Vinals, J. / Park, E. / Beyett, T.S. / Eck, M.J.
History
DepositionNov 20, 2022Deposition site: RCSB / Processing site: RCSB
Revision 1.0Apr 12, 2023Provider: repository / Type: Initial release
Revision 1.1May 3, 2023Group: Database references / Category: citation / Item: _citation.journal_volume / _citation.title
Revision 1.2May 22, 2024Group: Data collection / Category: chem_comp_atom / chem_comp_bond

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: Serine/threonine-protein kinase B-raf
B: Serine/threonine-protein kinase B-raf
hetero molecules


Theoretical massNumber of molelcules
Total (without water)65,0424
Polymers64,0292
Non-polymers1,0132
Water0
1


  • Idetical with deposited unit
  • defined by author
  • Evidence: gel filtration
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
Unit cell
Length a, b, c (Å)86.918, 121.998, 57.797
Angle α, β, γ (deg.)90.00, 90.00, 90.00
Int Tables number18
Space group name H-MP21212

-
Components

#1: Protein Serine/threonine-protein kinase B-raf / Proto-oncogene B-Raf / p94 / v-Raf murine sarcoma viral oncogene homolog B1


Mass: 32014.682 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: BRAF, BRAF1, RAFB1 / Production host: Escherichia coli BL21 (bacteria)
References: UniProt: P15056, non-specific serine/threonine protein kinase
#2: Chemical ChemComp-QOP / 6-amino-5-chloro-N-[(1R)-1-(5-{[5-chloro-4-(trifluoromethyl)pyridin-2-yl]carbamoyl}-1,3-thiazol-2-yl)ethyl]pyrimidine-4-carboxamide / tovorafenib


Mass: 506.289 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: C17H12Cl2F3N7O2S / Feature type: SUBJECT OF INVESTIGATION
Has ligand of interestY

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.32 Å3/Da / Density % sol: 47.04 %
Crystal growTemperature: 293 K / Method: vapor diffusion, hanging drop / pH: 8 / Details: 8% tacimate pH 8.0, 20% PEG 3350

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: APS / Beamline: 24-ID-C / Wavelength: 0.9786 Å
DetectorType: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Aug 16, 2018
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 0.9786 Å / Relative weight: 1
ReflectionResolution: 3.43→200 Å / Num. obs: 8092 / % possible obs: 95.9 % / Redundancy: 12.5 % / CC1/2: 0.968 / Rmerge(I) obs: 0.468 / Rrim(I) all: 0.489 / Net I/σ(I): 3.79
Reflection shell
Resolution (Å)Rmerge(I) obsNum. unique obsCC1/2Rrim(I) allDiffraction-ID
3.43-3.642.19110800.472.2831
3.64-3.891.44812560.7091.5081
3.89-4.210.98111650.761.0231
4.21-4.610.68610640.8630.7161
4.61-5.150.5839520.8830.6091
5.15-5.940.5118710.9410.5331
5.94-7.270.3567560.980.3721
7.27-10.270.2335740.9650.2451
10.27-2000.2323740.9660.2431

-
Processing

Software
NameVersionClassification
XDSdata scaling
PHENIX1.2refinement
XDSdata reduction
PHASERphasing
Cootmodel building
RefinementMethod to determine structure: MOLECULAR REPLACEMENT / Resolution: 3.54→70.79 Å / SU ML: 0.46 / Cross valid method: FREE R-VALUE / σ(F): 1.35 / Phase error: 25.67 / Stereochemistry target values: ML
RfactorNum. reflection% reflection
Rfree0.2693 752 10 %
Rwork0.2151 --
obs0.2207 7519 94.48 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.1 Å / Solvent model: FLAT BULK SOLVENT MODEL
Refinement stepCycle: LAST / Resolution: 3.54→70.79 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms4195 0 64 0 4259
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0024359
X-RAY DIFFRACTIONf_angle_d0.4965882
X-RAY DIFFRACTIONf_dihedral_angle_d11.9531640
X-RAY DIFFRACTIONf_chiral_restr0.042634
X-RAY DIFFRACTIONf_plane_restr0.003752
LS refinement shell
Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection RworkRefine-ID% reflection obs (%)
3.54-3.810.3141500.27641357X-RAY DIFFRACTION97
3.81-4.190.29811480.24071335X-RAY DIFFRACTION96
4.19-4.80.25391470.2021321X-RAY DIFFRACTION93
4.8-6.040.29391510.22011353X-RAY DIFFRACTION95
6.05-70.790.23451560.18591401X-RAY DIFFRACTION92
Refinement TLS params.

Method: refined / Refine-ID: X-RAY DIFFRACTION

IDL112)L122)L132)L222)L232)L332)S11 (Å °)S12 (Å °)S13 (Å °)S21 (Å °)S22 (Å °)S23 (Å °)S31 (Å °)S32 (Å °)S33 (Å °)T112)T122)T132)T222)T232)T332)Origin x (Å)Origin y (Å)Origin z (Å)
10.7851-0.1590.20562.80220.84292.54920.21840.64680.1062-0.8853-0.1723-0.2878-0.4288-0.4405-0.12011.07670.05430.0480.79730.20560.7820.117236.9587-5.01
21.21080.91840.87573.5371-0.22243.1941-0.05270.54540.91260.6090.2158-0.22480.23070.3276-0.11640.85650.12620.09980.8370.07520.883824.385334.72953.2733
33.0398-0.8321-0.64392.8138-0.0212.87230.17150.3493-0.01420.20470.02090.34860.2374-0.0463-0.11260.83040.0812-0.04060.6845-0.01330.78899.972230.494114.404
42.5595-3.0402-0.51713.60650.80763.68160.1993-0.94361.21490.81030.04210.1087-0.5696-0.2034-0.14991.0123-0.01260.09930.96610.02321.120215.257339.206924.9299
52.6552-0.1717-1.06773.9248-0.23152.94050.2434-0.22131.14220.6507-0.00250.1187-0.4686-0.4013-0.14431.04640.12770.22360.83320.03630.87156.231336.947830.1235
62.60540.4719-1.40474.19-0.73491.55580.5993-0.0305-1.09361.95640.3048-0.79970.3817-0.5107-0.06960.76090.1831-0.13611.2644-0.02161.250713.457318.455426.7068
71.2185-0.20340.55646.1562-0.80612.5705-0.1333-0.8107-0.44531.14450.6155-1.06150.28490.0626-0.06541.52070.2558-0.12560.8277-0.03190.591429.19279.830816.0283
84.8022-2.9556-0.75522.5512.46025.4333-1.012-1.4349-0.23131.15730.5161-2.20591.03230.2747-0.2491.13210.3639-0.06570.85430.07871.570432.10549.866114.6863
93.07970.6982-0.54830.58271.09163.569-0.2587-0.37890.0643-0.6506-0.1819-1.6331-0.0205-0.25380.15920.46640.1934-0.0331.4968-0.15681.438739.168713.11794.3439
100.3362-0.55520.76193.27120.45981.9746-0.5579-0.64450.10680.47570.38070.3466-0.2181-0.4936-0.07770.78670.02830.12180.86980.15240.699321.36210.19324.6002
114.02140.27771.37183.17280.98753.5852-0.0889-0.3012-0.033-0.12970.3901-0.02910.35320.1413-0.05341.04570.04430.21390.7756-0.03150.784921.559811.8359-4.268
125.2971-2.7819-0.73752.06980.22790.20980.593-0.96990.62020.1654-0.9295-0.04710.3161-0.17650.02850.79030.0174-0.12680.8254-0.10991.061350.56422.4629-12.4902
132.7701-0.2484-0.47032.68530.59791.52190.4030.0462-0.2872-0.7575-0.3466-0.1915-0.01180.4898-0.12041.05820.00690.13150.89690.01110.9622.9985-1.5229-14.4124
141.59780.48051.62662.83480.19141.58450.75170.9040.8606-1.0633-0.58970.3656-0.0957-0.0304-0.06391.1674-0.0380.13350.9512-0.04580.962317.42559.3326-20.1059
Refinement TLS group
IDRefine-IDRefine TLS-IDSelection details
1X-RAY DIFFRACTION1chain 'A' and (resid 449 through 491 )
2X-RAY DIFFRACTION2chain 'A' and (resid 492 through 533 )
3X-RAY DIFFRACTION3chain 'A' and (resid 534 through 619 )
4X-RAY DIFFRACTION4chain 'A' and (resid 620 through 651 )
5X-RAY DIFFRACTION5chain 'A' and (resid 652 through 706 )
6X-RAY DIFFRACTION6chain 'A' and (resid 707 through 723 )
7X-RAY DIFFRACTION7chain 'B' and (resid 449 through 475 )
8X-RAY DIFFRACTION8chain 'B' and (resid 476 through 491 )
9X-RAY DIFFRACTION9chain 'B' and (resid 492 through 507 )
10X-RAY DIFFRACTION10chain 'B' and (resid 508 through 549 )
11X-RAY DIFFRACTION11chain 'B' and (resid 550 through 611 )
12X-RAY DIFFRACTION12chain 'B' and (resid 612 through 634 )
13X-RAY DIFFRACTION13chain 'B' and (resid 635 through 670 )
14X-RAY DIFFRACTION14chain 'B' and (resid 671 through 722 )

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more